Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Treasury Shares: 2023-2025

  • Camp4 Therapeutics' Treasury Shares was N/A to $4,277 in Q1 2025 from the same period last year, while for Mar 2025 it was $4,277, marking a year-over-year change of. This contributed to the annual value of $15,943 for FY2024, which is 78.53% down from last year.
  • According to the latest figures from Q1 2025, Camp4 Therapeutics' Treasury Shares is $4,277, which was down 73.17% from $15,943 recorded in Q4 2024.
  • Camp4 Therapeutics' 5-year Treasury Shares high stood at $74,243 for Q4 2023, and its period low was $4,277 during Q1 2025.
  • Moreover, its 3-year median value for Treasury Shares was $23,275 (2024), whereas its average is $31,268.
  • Data for Camp4 Therapeutics' Treasury Shares shows a maximum YoY slumped of 78.53% (in 2024) over the last 5 years.
  • Camp4 Therapeutics' Treasury Shares (Quarterly) stood at $74,243 in 2023, then plummeted by 78.53% to $15,943 in 2024, then reached $4,277 in 2025.
  • Its Treasury Shares stands at $4,277 for Q1 2025, versus $15,943 for Q4 2024 and $30,607 for Q3 2024.